Pathways for Modulating Exosome Lipids Identified by High-Density Lipoprotein-Like Nanoparticle Binding to Scavenger Receptor Type B-1

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Angeloni, Nicholas L ^a   McMahon, Kaylin M ^a,b   Swaminathan, Suchitra ^a   Plebanek, Michael P ^a,b   Osman, Iman ^c,d   Volpert, Olga V ^a   Thaxton, C Shad ^a,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIGAND; NANOPARTICLE; PHOSPHOLIPID; PROTEIN BINDING; SCAVENGER RECEPTOR B;

BLOOD; CELL COMMUNICATION; CHEMISTRY; EXOSOME; GENETIC PROCEDURES; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LIPID METABOLISM; METABOLISM;

BIOSENSING TECHNIQUES; CELL COMMUNICATION; EXOSOMES; HUMANS; LIGANDS; LIPID METABOLISM; LIPOPROTEINS, HDL; NANOPARTICLES; PHOSPHOLIPIDS; PROTEIN BINDING; SCAVENGER RECEPTORS, CLASS B;

EID: 84960938173     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep22915     Document Type: Article

References (28)

1. Vlassov, A. V., Magdaleno, S., Setterquist, R., Conrad, R. Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. Biochim. Biophys. Acta 1820, 940-948 (2012).
2. Melo, S. A. et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523, 177-182 (2015).
3. Yu, S., Cao, H., Shen, B., Feng, J. Tumor-derived exosomes in cancer progression and treatment failure. Oncotarget (2015).
4. Challagundla, K. B. et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J. Natl. Cancer I. 107 (2015).
5. Lydic, T. A. et al. Rapid and comprehensive 'shotgun' lipidome profiling of colorectal cancer cell derived exosomes. Methods, doi: 10.1016/j.ymeth.2015.04.014 (2015).
6. Peinado, H. et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat. Med. 18, 883-891 (2012).
7. Katakowski, M. et al. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett. 335, 201-204 (2013).
8. Rana, S., Yue, S., Stadel, D., Zoller, M. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int. J. Biochem. Cell B. 44, 1574-1584 (2012).
9. Johnsen, K. B. et al. A comprehensive overview of exosomes as drug delivery vehicles-endogenous nanocarriers for targeted cancer therapy. Biochim. Biophys. Acta 1846, 75-87 (2014).
10. Zitvogel, L. et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med. 4, 594-600 (1998).
11. Kharaziha, P. et al. Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. Oncotarget 6, 21740-21754 (2015).
12. Lazar, I. et al. Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines. Pigment Cell Melanoma Res. 28, 464-475 (2015).
13. Urban, S. et al. Scavenger receptor BI transfers major lipoprotein-associated phospholipids into the cells. J. Biol. Chem. 275, 33409-33415 (2000).
14. Luthi, A. J. et al. Nanotechnology for synthetic high-density lipoproteins. Trends Mol. Med. 16, 553-560 (2010).
15. Luthi, A. J. et al. Tailoring of biomimetic high-density lipoprotein nanostructures changes cholesterol binding and efflux. ACS Nano 6, 276-285 (2012).
16. Thaxton, C. S., Daniel, W. L., Giljohann, D. A., Thomas, A. D., Mirkin, C. A. Templated spherical high density lipoprotein nanoparticles. J. Am. Chem. Soc. 131, 1384-1385 (2009).
17. Luthi, A. J. et al. Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein. J. Lipid Res. 56, 972-985 (2015).
18. Tripathy, S., Vinokour, E., McMahon, K. M., Volpert, O. V., Thaxton, C. S. High Density Lipoprotein Nanoparticles Deliver RNAi to Endothelial Cells to Inhibit Angiogenesis. Part. Part. Syst. Char. 31, 1141-1150 (2014).
19. Yang, S. et al. Biomimetic, synthetic HDL nanostructures for lymphoma. Proc. Natl. Acad. Sci. 110, 2511-2516 (2013).
20. Damiano, M. G., Mutharasan, R. K., Tripathy, S., McMahon, K. M., Thaxton, C. S. Templated high density lipoprotein nanoparticles as potential therapies and for molecular delivery. Adv. Drug Deliver. Rev. 65, 649-662 (2013).
21. McMahon, K. M. et al. Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery. Nano Lett. 11, 1208-1214 (2011).
22. Perez-Hernandez, D. et al. The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes. J. Biol. Chem. 288, 11649-11661 (2013).
23. Rana, S., Zoller, M. Exosome target cell selection and the importance of exosomal tetraspanins: a hypothesis. Biochem. Soc. T. 39, 559-562 (2011).
24. Thery, C., Amigorena, S., Raposo, G., Clayton, A. Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr. Protoc. Cell Biol. Chapter 3, Unit 3 22 (2006).
25. Nolan, J. P. Flow Cytometry of Extracellular Vesicles: Potential, Pitfalls, and Prospects. Curr. Protoc. Cytom. 73, 13 14 11-13 14 16 (2015).
26. Plebanek, M. P. et al. Nanoparticle Targeting and Cholesterol Flux Through Scavenger Receptor Type B-1 Inhibits Cellular Exosome Uptake. Sci. Rep. 5, 15724, doi: 10.1038/srep15724 (2015).
27. Lavie, M. et al. Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors. J. Virol. 88, 10584-10597 (2014).
28. Rocha-Perugini, V. et al. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry. BMC Microbiol. 9, 111 (2009).